116 related articles for article (PubMed ID: 21252085)
1. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia.
Rudkin AK; Muecke JS
Br J Ophthalmol; 2011 Jul; 95(7):947-50. PubMed ID: 21252085
[TBL] [Abstract][Full Text] [Related]
2. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study.
Parrozzani R; Lazzarini D; Alemany-Rubio E; Urban F; Midena E
Br J Ophthalmol; 2011 Mar; 95(3):355-9. PubMed ID: 20693564
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ocular surface squamous neoplasia with Mitomycin C.
Gupta A; Muecke J
Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
Bahrami B; Greenwell T; Muecke JS
Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
[TBL] [Abstract][Full Text] [Related]
5. Topical chemotherapy for ocular surface squamous neoplasia: current status.
Sepulveda R; Pe'er J; Midena E; Seregard S; Dua HS; Singh AD
Br J Ophthalmol; 2010 May; 94(5):532-5. PubMed ID: 19776089
[TBL] [Abstract][Full Text] [Related]
6. Intralesional bevacizumab use for invasive ocular surface squamous neoplasia.
Paul S; Stone DU
J Ocul Pharmacol Ther; 2012 Dec; 28(6):647-9. PubMed ID: 22900896
[TBL] [Abstract][Full Text] [Related]
7. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
Sturges A; Butt AL; Lai JE; Chodosh J
Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
[TBL] [Abstract][Full Text] [Related]
8. Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia.
Chen C; Louis D; Dodd T; Muecke J
Br J Ophthalmol; 2004 Jan; 88(1):17-8. PubMed ID: 14693762
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
10. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications.
Russell HC; Chadha V; Lockington D; Kemp EG
Br J Ophthalmol; 2010 Oct; 94(10):1316-21. PubMed ID: 20530655
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant treatment or primary topical monotherapy for ocular surface squamous neoplasia: a systematic review.
Viani GA; Fendi LI
Arq Bras Oftalmol; 2017; 80(2):131-136. PubMed ID: 28591290
[TBL] [Abstract][Full Text] [Related]
13. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
[TBL] [Abstract][Full Text] [Related]
14. Ocular surface squamous neoplasia: a standard of care survey.
Stone DU; Butt AL; Chodosh J
Cornea; 2005 Apr; 24(3):297-300. PubMed ID: 15778602
[TBL] [Abstract][Full Text] [Related]
15. Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial.
Gichuhi S; Macharia E; Kabiru J; Zindamoyen AM; Rono H; Ollando E; Wachira J; Munene R; Maina J; Onyuma T; Sagoo MS; Weiss HA; Burton MJ
Lancet Glob Health; 2016 Jun; 4(6):e378-85. PubMed ID: 27198842
[TBL] [Abstract][Full Text] [Related]
16. Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival/perilesional 5-fluorouracil injections.
Sun Y; Hua R
Drug Des Devel Ther; 2019; 13():1323-1334. PubMed ID: 31118569
[No Abstract] [Full Text] [Related]
17. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
Joag MG; Sise A; Murillo JC; Sayed-Ahmed IO; Wong JR; Mercado C; Galor A; Karp CL
Ophthalmology; 2016 Jul; 123(7):1442-8. PubMed ID: 27030104
[TBL] [Abstract][Full Text] [Related]
18. Observational study of ocular surface squamous neoplasia: Risk factors, diagnosis, management and outcomes at a tertiary eye hospital in South Africa.
Hӧllhumer R; Williams S; Michelow P
PLoS One; 2020; 15(8):e0237453. PubMed ID: 32780766
[TBL] [Abstract][Full Text] [Related]
19. [Interferon alpha 2β, partial keratectomy and amniotic membrane transplant for the treatment of a recurrent conjunctival squamous carcinoma].
Verdaguer P; Fideliz de la Paz M; Alvarez de Toledo JP; Barraquer RI
Arch Soc Esp Oftalmol; 2011 May; 86(5):154-7. PubMed ID: 21624656
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant 5-fluorouracil lacquer administration for reducing the rate of recurrence of condylomata acuminata following laser surgery treatment].
Erpenbach K; Derschum W; von Vietsch H; Reis M
Urologe A; 1989 May; 28(3):158-62. PubMed ID: 2741263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
